image
Healthcare - Medical - Care Facilities - NYSE - US
$ 160.33
3.87 %
$ 13.1 B
Market Cap
17.28
P/E
1. INTRINSIC VALUE

DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services.[ Read More ]

The intrinsic value of one DVA stock under the base case scenario is HIDDEN Compared to the current market price of 160 USD, DaVita Inc. is HIDDEN

2. FUNDAMENTAL ANALYSIS

Price Chart DVA

image
FINANCIALS
12.1 B REVENUE
4.57%
1.6 B OPERATING INCOME
19.69%
692 M NET INCOME
-11.53%
2.06 B OPERATING CASH FLOW
31.60%
-772 M INVESTING CASH FLOW
-22.44%
-1.17 B FINANCING CASH FLOW
-4.62%
3.26 B REVENUE
2.41%
535 M OPERATING INCOME
6.78%
296 M NET INCOME
32.82%
810 M OPERATING CASH FLOW
0.98%
-143 M INVESTING CASH FLOW
26.89%
-10.9 M FINANCING CASH FLOW
97.96%
Balance Sheet Decomposition DaVita Inc.
image
Current Assets 3.14 B
Cash & Short-Term Investments 392 M
Receivables 2.42 B
Other Current Assets 330 M
Non-Current Assets 14.5 B
Long-Term Investments 594 M
PP&E 5.57 B
Other Non-Current Assets 8.31 B
Current Liabilities 2.64 B
Accounts Payable 515 M
Short-Term Debt 518 M
Other Current Liabilities 1.61 B
Non-Current Liabilities 12.2 B
Long-Term Debt 10.6 B
Other Non-Current Liabilities 1.63 B
EFFICIENCY
Earnings Waterfall DaVita Inc.
image
Revenue 12.1 B
Cost Of Revenue 8.32 B
Gross Profit 3.82 B
Operating Expenses 1.47 B
Operating Income 1.6 B
Other Expenses 911 M
Net Income 692 M
RATIOS
31.47% GROSS MARGIN
31.47%
13.20% OPERATING MARGIN
13.20%
5.70% NET MARGIN
5.70%
65.48% ROE
65.48%
3.92% ROA
3.92%
14.12% ROIC
14.12%
FREE CASH FLOW ANALYSIS
Free Cash Flow Analysis DaVita Inc.
image
Net Income 692 M
Depreciation & Amortization 745 M
Capital Expenditures -568 M
Stock-Based Compensation 112 M
Change in Working Capital 195 M
Others 382 M
Free Cash Flow 1.49 B
3. WALL STREET ANALYSTS ESTIMATES
Wall Street Analysts Price Targets DaVita Inc.
image
Wall Street analysts predict an average 1-year price target for DVA of $125 , with forecasts ranging from a low of $81 to a high of $150 .
DVA Lowest Price Target Wall Street Target
81 USD -49.48%
DVA Average Price Target Wall Street Target
125 USD -21.77%
DVA Highest Price Target Wall Street Target
150 USD -6.44%
4. DIVIDEND ANALYSIS
0.00% DIVIDEND YIELD
0 USD DIVIDEND PER SHARE
5. COMPETITION
6. Ownership
Insider Ownership DaVita Inc.
image
Sold
0-3 MONTHS
26.8 M USD 2
3-6 MONTHS
7.47 M USD 2
6-9 MONTHS
18.2 M USD 5
9-12 MONTHS
0 USD 0
Bought
0 USD 0
0-3 MONTHS
0 USD 0
3-6 MONTHS
0 USD 0
6-9 MONTHS
0 USD 0
9-12 MONTHS
Date Value Insider Amount Avg Price
2 months ago
Sep 13, 2024
Sell 1.61 M USD
Rodriguez Javier
Chief Executive Officer
- 9881
162.8501 USD
2 months ago
Sep 16, 2024
Sell 8.25 M USD
Rodriguez Javier
Chief Executive Officer
- 50000
165.0503 USD
2 months ago
Aug 27, 2024
Sell 9.93 M USD
ACKERMAN JOEL
CFO and Treasuer
- 64029
155.0639 USD
2 months ago
Aug 28, 2024
Sell 735 K USD
ACKERMAN JOEL
CFO and Treasuer
- 4740
155.0179 USD
2 months ago
Aug 26, 2024
Sell 5.02 M USD
Rodriguez Javier
Chief Executive Officer
- 32176
155.9331 USD
2 months ago
Aug 27, 2024
Sell 1.24 M USD
Rodriguez Javier
Chief Executive Officer
- 7943
155.9346 USD
3 months ago
Aug 15, 2024
Sell 1.43 M USD
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
- 9539
150.0289 USD
3 months ago
Aug 16, 2024
Sell 4.89 M USD
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
- 32580
150.1652 USD
3 months ago
Aug 13, 2024
Sell 1.15 M USD
Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
- 7857
146.2093 USD
6 months ago
May 10, 2024
Sell 698 K USD
DESOER BARBARA J
Director
- 5030
138.81 USD
8 months ago
Feb 26, 2024
Sell 8.53 M USD
Rodriguez Javier
Chief Executive Officer
- 67603
126.1058 USD
8 months ago
Feb 27, 2024
Sell 938 K USD
Rodriguez Javier
Chief Executive Officer
- 7397
126.8713 USD
8 months ago
Feb 21, 2024
Sell 3.53 M USD
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
- 29488
119.8123 USD
8 months ago
Feb 21, 2024
Sell 1.36 M USD
Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
- 11285
120.73 USD
9 months ago
Feb 16, 2024
Sell 3.13 M USD
HEARTY JAMES O
Chief Compliance Officer
- 26164
119.6403 USD
1 year ago
Aug 22, 2023
Sell 997 K USD
Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
- 9794
101.8071 USD
1 year ago
May 12, 2023
Sell 209 K USD
YALE PHYLLIS R
Director
- 2196
95.262 USD
1 year ago
May 10, 2023
Sell 1.54 M USD
Rodriguez Javier
Chief Executive Officer
- 15516
99.383 USD
1 year ago
May 10, 2023
Sell 140 K USD
Rodriguez Javier
Chief Executive Officer
- 1400
100.0443 USD
1 year ago
May 10, 2023
Sell 1.58 M USD
Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
- 15941
99.2403 USD
1 year ago
May 10, 2023
Sell 584 K USD
HEARTY JAMES O
Chief Compliance Officer
- 5745
101.6386 USD
1 year ago
May 10, 2023
Sell 249 K USD
DESOER BARBARA J
Director
- 2449
101.61 USD
1 year ago
Mar 09, 2023
Sell 108 K USD
BERG CHARLES
Director
- 1431
75.1317 USD
1 year ago
Mar 01, 2023
Sell 60.1 K USD
BERG CHARLES
Director
- 735
81.7798 USD
2 years ago
Nov 01, 2022
Bought 356 K USD
NEHRA JOHN M
Director
+ 5000
71.135 USD
2 years ago
Jun 23, 2022
Bought 1.55 M USD
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
+ 20000
77.7 USD
2 years ago
Jun 03, 2022
Sell 226 K USD
DESOER BARBARA J
director:
- 2320
97.418 USD
2 years ago
Feb 14, 2022
Sell 79.6 K USD
Price Paula A
Director
- 700
113.644 USD
2 years ago
Nov 23, 2021
Sell 45.9 K USD
Arway Pamela M
Director
- 446
102.86 USD
3 years ago
Aug 23, 2021
Sell 48.6 K USD
Arway Pamela M
Director
- 365
133.09 USD
3 years ago
Aug 05, 2021
Sell 4.96 M USD
ACKERMAN JOEL
CFO & Treasurer
- 37760
131.3598 USD
3 years ago
Aug 05, 2021
Sell 105 K USD
Price Paula A
Director
- 790
132.6632 USD
3 years ago
Jun 23, 2021
Sell 0 USD
Cheshire MD Holdings, LLC
10 percent owner
- 192000
0 USD
3 years ago
Jun 22, 2021
Sell 628 K USD
YALE PHYLLIS R
Director
- 5048
124.3266 USD
3 years ago
May 24, 2021
Sell 46.7 K USD
Arway Pamela M
Director
- 379
123.12 USD
3 years ago
May 13, 2021
Sell 242 K USD
DESOER BARBARA J
Director
- 1920
126.0128 USD
3 years ago
May 04, 2021
Sell 108 K USD
HEARTY JAMES O
Chief Compliance Officer
- 884
121.885 USD
3 years ago
May 04, 2021
Sell 229 K USD
BERG CHARLES
Director
- 1872
122.52 USD
3 years ago
May 05, 2021
Sell 3.31 M USD
Rodriguez Javier
Chief Executive Officer
- 27053
122.2248 USD
3 years ago
May 03, 2021
Sell 626 K USD
Waters Kathleen Alyce
Chief Legal & Pub. Affairs Off
- 5290
118.364 USD
3 years ago
Mar 22, 2021
Sell 47.7 K USD
Arway Pamela M
Director
- 436
109.51 USD
3 years ago
Nov 30, 2020
Sell 2.74 M USD
STAFFIERI MICHAEL DAVID
Chief Operating Officer, DKC
- 25000
109.7406 USD
3 years ago
Nov 20, 2020
Sell 46.4 K USD
Arway Pamela M
Director
- 430
107.88 USD
4 years ago
Nov 17, 2020
Sell 154 K USD
DESOER BARBARA J
Director
- 1388
111 USD
4 years ago
Nov 16, 2020
Sell 818 K USD
Arway Pamela M
Director
- 7326
111.63 USD
4 years ago
Nov 10, 2020
Sell 204 K USD
Waters Kathleen Alyce
Chief Legal Officer
- 2000
102 USD
4 years ago
Nov 10, 2020
Sell 846 K USD
Waters Kathleen Alyce
Chief Legal Officer
- 8000
105.7661 USD
4 years ago
Sep 23, 2020
Bought 83.6 K USD
NEHRA JOHN M
Director
+ 1000
83.55 USD
4 years ago
Sep 23, 2020
Bought 124 K USD
NEHRA JOHN M
Director
+ 1500
82.549 USD
4 years ago
Sep 22, 2020
Bought 254 K USD
NEHRA JOHN M
Director
+ 3000
84.6048 USD
4 years ago
Sep 18, 2020
Sell 214 K USD
ZUMWALT LEANNE M
Group VP, Government Affairs
- 2435
87.7282 USD
4 years ago
Sep 18, 2020
Sell 118 K USD
ZUMWALT LEANNE M
Group VP, Government Affairs
- 1337
88.5658 USD
4 years ago
Sep 17, 2020
Sell 176 M USD
WESCHLER, R. TED
- 2000000
88 USD
4 years ago
Sep 17, 2020
Sell 17.6 M USD
WESCHLER, R. TED
- 200000
88 USD
4 years ago
Sep 17, 2020
Sell 176 M USD
BERKSHIRE HATHAWAY INC
10 percent owner
- 2000000
88 USD
4 years ago
Aug 24, 2020
Sell 50.3 K USD
Arway Pamela M
Director
- 578
87.02 USD
4 years ago
Jun 08, 2020
Sell 31.2 K USD
BERG CHARLES
Director
- 357
87.532 USD
4 years ago
Jun 08, 2020
Sell 31 K USD
ROPER WILLIAM L
Director
- 357
86.7885 USD
4 years ago
Jun 08, 2020
Sell 31.2 K USD
Arway Pamela M
Director
- 357
87.323 USD
4 years ago
May 22, 2020
Sell 47.3 K USD
Arway Pamela M
Director
- 599
78.9 USD
4 years ago
May 18, 2020
Sell 397 K USD
DIAZ PAUL J
Director
- 4821
82.2645 USD
4 years ago
May 18, 2020
Sell 52.2 K USD
DIAZ PAUL J
Director
- 635
82.1623 USD
4 years ago
May 18, 2020
Sell 25.1 K USD
DIAZ PAUL J
Director
- 307
81.6119 USD
7. News
DaVita: Better Results Than Fresenius, But A 'Hold' Due To Valuation Despite operational success and growth potential, I rate DaVita Inc. a “Hold” due to its high debt, lack of dividend, and current overvaluation. DaVita excels in dialysis services but faces significant risks from debt servicing costs, macroeconomic factors, and potential policy changes. The company's recent financial performance, including a decline in net income and increased debt costs, underscores my conservative valuation approach. seekingalpha.com - 2 days ago
DaVita's "Move It With Purpose" Sets Record Participation in Support of Global Health More than 8,300 people joined the annual event to raise funds for Bridge of Life DENVER , Nov. 12, 2024 /PRNewswire/ -- DaVita, a leading provider of kidney care services, today announced the success of its third annual Move It With Purpose (MIWP) event with more than 8,300 participants, including DaVita teammates, friends, family and key members of the kidney care community. The month-long initiative encourages physical activity — whether it's walking, running, swimming, bicycling or other activities — to benefit Bridge of Life, a nonprofit founded by DaVita to support the prevention and treatment of chronic disease globally. prnewswire.com - 4 days ago
DaVita Inc. to Participate in UBS Global Healthcare Conference 2024 DENVER , Nov. 8, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) today announced that its chief financial officer, Joel Ackerman, and its group vice president of investor relations, Nic Eliason, will participate in a fireside chat with investors at UBS Global Healthcare Conference 2024 on Tuesday, November 12, 2024 at 12:30 pm PST (3:30 pm EST). To view the live webcast, visit the UBS page here and create a free registration. prnewswire.com - 1 week ago
Why DaVita Stock Withered on Wednesday The company's profitability is going in the wrong direction for many investors. fool.com - 2 weeks ago
Two Warren Buffett Stocks Get Pounded, With Apple Earnings Due This week marks a fire hose of earnings from several top Warren Buffett stock holdings. "Extraordinary business" Apple is on deck Thursday. investors.com - 2 weeks ago
DaVita Stock Declines After Q3 Earnings Miss Estimates, Margins Up DVA's robust Dialysis patient service revenues drives its third-quarter performance. zacks.com - 2 weeks ago
DaVita Inc. (DVA) Q3 2024 Earnings Call Transcript DaVita Inc. (NYSE:DVA ) Q3 2024 Earnings Conference Call October 29, 2024 5:00 PM ET Company Participants Nic Eliason - Group Vice President, Investor Relations Javier Rodriguez - Chief Executive Officer Joel Ackerman - Chief Financial Officer Conference Call Participants Andrew Mok - Barclays AJ Rice - UBS Pito Chickering - Deutsche Bank Lisa Clive - Bernstein Joanna Gajuk - Bank of America Ryan Langston - TD Cowen Justin Lake - Wolfe Research Operator Good evening. My name is Michelle and I will be your conference facilitator today. seekingalpha.com - 2 weeks ago
DaVita HealthCare (DVA) Q3 Earnings Miss Estimates DaVita HealthCare (DVA) came out with quarterly earnings of $2.59 per share, missing the Zacks Consensus Estimate of $2.76 per share. This compares to earnings of $2.85 per share a year ago. zacks.com - 2 weeks ago
DaVita misses third-quarter profit estimates on higher costs DaVita reported third-quarter profit that missed Wall Street estimates on Tuesday, hurt by high patient care costs. reuters.com - 2 weeks ago
DaVita Inc. 3rd Quarter 2024 Results DENVER , Oct. 29, 2024 /PRNewswire/ -- DaVita Inc. (NYSE: DVA) announced financial and operating results for the quarter ended September 30, 2024. "We continue to provide quality care for our patients across the continuum of care, while delivering solid third quarter financial performance," said Javier Rodriguez, CEO of DaVita Inc. "And, in light of recent severe storms, I am grateful for the remarkable resilience of our patients and our frontline caregivers. prnewswire.com - 2 weeks ago
6 Stocks Dominate Market's 'Best 6 Months' — Starting This Week If you had to choose the best time to invest in the S&P 500 — it's the six months starting in November. investors.com - 2 weeks ago
DaVita Emphasizes Commitment to Whole-Person Care with Investment in National Kidney Foundation PEERS Program The program aims to bring together a supportive network for people dealing with chronic health challenges for themselves and their loved ones DENVER , Oct. 28, 2024 /PRNewswire/ -- The DaVita Giving Foundation today announced an investment in the National Kidney Foundation (NKF)'s PEERS program, a program that provides social and emotional support for patients, care partners, and living donors through connections with mentors living through similar experiences. Prioritizing mental health in chronic disease care is essential, and mentorship can help provide people with support and comfort in a time when they might otherwise feel alone. prnewswire.com - 2 weeks ago
8. Profile Summary

DaVita Inc. DVA

image
COUNTRY US
INDUSTRY Medical - Care Facilities
MARKET CAP $ 13.1 B
Dividend Yield 0.00%
Description DaVita Inc. provides kidney dialysis services for patients suffering from chronic kidney failure. The company operates kidney dialysis centers and provides related lab services in outpatient dialysis centers. It also provides outpatient, hospital inpatient, and home-based hemodialysis services; owns clinical laboratories that provide routine laboratory tests for dialysis and other physician-prescribed laboratory tests for ESRD patients; and management and administrative services to outpatient dialysis centers. In addition, the company provides disease management services to 16,000 patients in risk-based integrated care arrangements and 7,000 patients in other integrated care arrangements; vascular access services; clinical research programs; physician services; and comprehensive kidney care services. As of December 31, 2021, it provided dialysis and administrative services in the United States through a network of 2,815 outpatient dialysis centers serving approximately 203,100 patients; and operated 339 outpatient dialysis centers located in 10 countries outside of the United States serving approximately 39,900 patients. Further, the company provides acute inpatient dialysis services in approximately 850 hospitals and related laboratory services in the United States. The company was formerly known as DaVita HealthCare Partners Inc. and changed its name to DaVita Inc. in September 2016. DaVita Inc. was incorporated in 1994 and is headquartered in Denver, Colorado.
Contact 2000 16th Street, Denver, CO, 80202 https://www.davita.com
IPO Date Oct. 31, 1995
Employees 70000
Officers Mr. James O. Hearty Chief Compliance Officer Mr. David Maughan Chief Operating Officer Nic Eliason Group Vice President of Investor Relations Mr. Misha Palecek Chief Transformation Officer of U.S. Kidney Care Business Dr. Jeffrey Allen Giullian Chief Medical Officer of Kidney Care Ms. Jessica Hergenreter Chief People Officer Ms. Madhu Narasimhan Chief Information Officer Mr. Javier J. Rodriguez Chief Executive Officer & Executive Director Mr. Joel Ackerman Chief Financial Officer & Treasurer Ms. Kathleen Alyce Waters Chief Legal & Public Affairs Officer